Background Nonmodulation seems to represent an inheritable trait characterized by abnormal angiotensin-mediated control of aldosterone release and renal blood supply and salt-sensitive hypertension. Recently, we demonstrated that atrial natriuretic peptide (ANP) response to angiotensin II also is altered in nonmodulators. Moreover, an abnormal ANP response to acute volume expansion has been shown by others in hypertensive patients displaying some features of nonmodulators. These data induced us to hypothesize that nonmodulation could be characterized by an abnormal ANP response to saline load.
Background Nonmodulation seems to represent an inheritable trait characterized by abnormal angiotensin-mediated control of aldosterone release and renal blood supply and salt-sensitive hypertension. Recently, we demonstrated that atrial natriuretic peptide (ANP) response to angiotensin II also is altered in nonmodulators. Moreover, an abnormal ANP response to acute volume expansion has been shown by others in hypertensive patients displaying some features of nonmodulators. These data induced us to hypothesize that nonmodulation could be characterized by an abnormal ANP response to saline load.
Methods and Results Forty-three essential hypertensive men were subdivided into low-renin patients (n= 12), nonmodulators (n=15), and modulators (n=16) according to their renin profile and ability to modulate aldosterone and p-aminohippurate clearance responses to a graded angiotensin II infusion (1.0 ng -kg-1 * min`and 3.0 ng* kg`min`for 30 minutes each) on both a low-(10 mmol Na+ per day) and a high-(210 mmol Na+ per day) Na+ intake. The intravenous saline load (0.25 mL kg`1 min`for 2 hours) performed on a low-Nal diet increased plasma ANP levels in low-renin (from 14.30±4.68 to 23.30±7.52 fmol/mL at 120 minutes, P<.05) and modulating patients (from 10.95±3.55 to 18.21±5.42 fmol/mL at 120 minutes, P<.05), whereas it did not change the hormone levels in nonmodulators (from 10.77±3.25 to 13.83±5.70 fmol/mL at 120 minutes, P=NS). When patients switched from a low-to a high-NaCl diet, plasma ANP levels increased significantly in all groups. However, when the saline load was repeated on a high-NaCl intake, ANP levels increased in both low-renin and modulating patients (P<.05), whereas it failed to increase in nonmodulators.
Conclusions Nonmodulating hypertensive patients showed a reduced ANP response to saline infusion in the presence of a normal increase of plasma ANP with dietary NaCl load. The impaired ANP response to saline infusion could be due to a different distribution of volume load and contribute to determining the reduced ability to excrete sodium that is commonly described in nonmodulators. (Circulation. 1994; 90:2859 -2869 Key Words * hypertension * kidney * atrial natriuretic factor * renin * hormones E ssential hypertension is a heterogeneous syndrome in which different mechanisms might identify patient subsets, such as salt sensitivity, renin status, and adrenergic activity. [1] [2] [3] In this context, the so-called "nonmodulation" seems to represent a strongly inheritable phenotype45 characterized by abnormal aldosterone and renal blood flow response to angiotensin II, abnormal renal response to saline load, and salt-sensitive hypertension. [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] Although the most precise way to identify nonmodulating hypertensive patients is to assess the aldosterone increase after angiotensin II infusion on a low sodium intake and/or the p-aminohippurate (PAH) decrease after the same infusion on a high sodium intake,5 the nonmodulating phenotype is also characterized by elevated erythrocyte Na+ /Li+ countertransport,14 increased plasma and urine dopamine levels,15 and fasting hyperinsulinemia. 16 These findings suggest that the pathogenetic mechanisms involved in nonmodulation are related to an altered response of not only the zona glomerulosa but also the renal vasculature to the infused angiotensin.
In accordance with this hypothesis, we recently demonstrated16 that nonmodulating patients failed to increase plasma atrial natriuretic peptide (ANP) levels in response to an angiotensin II infusion, thus indicating that the cardiac myocyte response to angiotensin II also is altered in nonmodulation. Moreover, an impaired ANP response to saline load has been reported by Volpe et al17'8 in essential hypertensive patients dis- playing some characteristics of nonmodulation, such as reduced plasma renin activity (PRA) and aldosterone responses to saline infusion7"10"12"13 and decreased rate of sodium excretion.713 Taken together, these findings gave rise to the hypothesis that nonmodulators may be characterized by an abnormal ANP regulation involving the ANP response to both angiotensin II and saline infusions.
In the present study, we evaluated whether in human essential hypertension, the so-called nonmodulating phenotype5 was associated with an impaired ANP response to both saline and angiotensin II infusions. We also investigated whether changes in sodium intake were able to modify the ANP and the sodium excretory responses to both angiotensin II and saline infusions in the same patients. The 
Methods

Patients
The study protocol was accepted by our Ethics Committee. An informed written consent to take part in this study was requested of all the eligible hypertensive patients, who were selected from a cohort of male outpatients who had never been recruited for previous studies performed by our 21 A normal glucose tolerance was proved by the presence of fasting plasma glucose levels <6.0 mmol/L, absence of glycosuria, and plasma glucose levels 2 hours after oral glucose load (75 g) <7.7 mmol/L. All patients had normal serum cholesterol and triglyceride levels (ie, serum cholesterol <5.20 mmol/L and >3.80 mmol/L and serum triglycerides <1.7 mmol/L and >1.1 mmol/L).
During this part of the study, all patients were on a normocaloric diet with constant sodium intake (120 mmol NaCl daily) and took no medications for 6 weeks. The above sodium intake was achieved by a daily supplement of four capsules (each capsule containing 27.5 mmol NaCl) added to a diet containing about 1 g/kg protein, 2 g/kg carbohydrates, 0.5 g/kg fat, 10 mmol Na+, and 60 mmol K' per day. Participants were carefully instructed by us and experienced nutritionists on how to avoid any kind of high-sodium food, to appreciate low-sodium food, and to absolutely eliminate use of added salt. Adherence to the diet was assessed by measuring the 24-hour urinary sodium and chloride excretions on the last 3 days of each week. Patients were considered compliant when sodium and chloride excretions were >80 and <130 mmol/d. After 6 weeks of constant sodium intake, 9 patients were considered not compliant and were screened out. The remaining 56 patients continued the study, and a family history of hypertension and myocardial infarction was evaluated by a questionnaire and consultation with each primary care physician according to a previously described methodology. 22 In brief, at the first visit, patients were required to answer standard questions. During the following visits, patients' wives were asked to confirm previous information. The primary care physician was asked to give at least a final confirmation of the resulting family history. A positive history of hypertension or myocardial infarction was defined as the presence of at least one first-degree relative who had suffered from one or both of these conditions before the age of 55 years.1"'8 In the case of hypertension, prescribed antihypertensive medication was sufficient to consider the patient to be hypertensive. Family history was obtained in each case by researchers who were unaware of the study purpose, conditions, and results.
A group of 13 normotensive men (blood pressure levels < 140/90 mm Hg) without any of the above-cited family backgrounds served as control subjects. Both the inclusion criteria and the study conditions were identical to those used for hypertensive subjects.
The erythrocyte Na+/Li+ countertransport activity was also evaluated after at least 6 weeks of pharmacological washout.
Protocol
An overview of the study design is given in Fig 1. As is shown, after the definitive enrollment in the study, both hypertensive patients (n=56) and control subjects (n= 13) were hospitalized and continued the previous diet containing 120 mmol NaCl per day. During week 1 of hospitalization, 5 patients showed a supine diastolic blood pressure <95 mm Hg and were screened out. All the remaining patients (n=51) were assigned first to a low-(10 mmol Na+ per day for 2 weeks) and then to a high-(210 mmol Na+ per day for 2 weeks) sodium diet in a double-blind fashion. Both the low-and the high-sodium intakes were achieved by continuing the previous diet but substituting in a double-blind fashion the daily supplement of four capsules containing 27.5 mmol NaCl each with four identical capsules containing either placebo (meal) or 50 mmol NaCl each. Compliance to the diet was verified by measuring both sodium and chloride excretions on the last three days of each week. Three patients with a urinary excretion of Na+ >20 mmol/d during the low-sodium intake as well as 5 patients and 2 normotensive control subjects with a sodium excretion <180 mmol NaCl during the high-sodium 1 l intake were considered not compliant and were excluded from the study. Thus, the evaluation of the nonmodulating phenotype was performed in 43 hypertensive patients, and 11 normotensive subjects were enrolled in the control group. To avoid bias, all procedures regarding changes in sodium intake, adherence to the diet, and blood pressure measurements were made by a staff of researchers who were unaware of the conditions, the purpose, and the results of the study.
Identification of the Nonmodulating Phenotype
According to the criteria of Williams et al,5 low-renin patients were first identified as those having PRA levels after 1 hour of active orthostatism on a low-sodium intake (10 mmol Na+ per day for 1 week) that were <0.30 ng of angiotensin I per liter per second. '6 In hypertensive patients with a normal to high renin activity, the nonmodulating phenotype was defined as the simultaneous presence of the following two characteristics: (1) an aldosterone increase <420 pmol/L in response to angiotensin II infusion during a low-sodium diet (10 mmol Na+ per day for 7 days)512,13,16 and (2) a PAH clearance decrement <120 mL/min per 1.73 m2 in response to angiotensin II infusion during a high-sodium diet (210 mmol Na+ per day for 7 days).5,10,12,13,16
In particular, after 1 week on low-Na+ intake, blood samples for PRA evaluation were taken in both hypertensive and normotensive individuals after 1 hour of lying in the supine position and then again after 1 hour of upright posture. After blood collections, renal plasma flow was assessed in both hypertensive patients and control subjects according to the method described by Rystedt et al.7 Briefly, at 9:30 AM, after 1 hour with the patient in the supine position, an intravenous catheter was installed in the right arm. A control blood sample was obtained, and PAH (bolus injection of 8 mg/kg) was infused. A constant infusion of PAH (12 mg/min) was then started, with the infusion rate controlled by a peristaltic pump (Abbot/Shaw Life Care Pump). PAH clearance was calculated from the plasma concentrations and the infusion rate and corrected for body surface area. After basal PAH clearance was measured, angiotensin II amide (Hypertensin, CIBA-GEIGY Corp, Pharmaceutical Division) was infused at successive doses of 1.0 and 3.0 ng* kg.* minm1 for 30 minutes each, using the above-mentioned peristaltic pump, without discontinuing the contemporaneous PAH infusion.
During the angiotensin II infusion, blood samples for PRA, aldosterone, ANP, sodium, and potassium were drawn at time 0, 30, and 60 minutes by use of a heparin lock catheter system installed in an antecubital vein of the left forearm. Blood pressure was constantly measured every 5 minutes by a standard Riva-Rocci sphygmomanometer with the cuff position over the brachial artery of the left arm.
Before the angiotensin II infusion was begun, patients were asked to void at 8:30 AM to complete the previous 24-hour collection and to make a 1-hour collection before each infusion was begun. At the end of this procedure, another urine collection was made.
Saline Infusion
After the infusion of PAH and angiotensin II, both patients and control subjects continued the low-sodium intake for another week. At the end of this period, after an overnight fast, at 8 AM with the patient in the supine position, a catheter was inserted in an antecubital vein of the right forearm. 
High-Sodium Diet
Both the PAH and angiotensin II infusions as well as the intravenous saline load were repeated in each patient after 1 and 2 weeks on a high-sodium intake (210 mmol Na+ per day) (Fig 1) .
To 
Results
Baseline Comparison
Twelve hypertensive patients had a low renin activity and 31 a normal to high activity (ie, a PRA >0.30 ng angiotensin I per liter per second after 1 hour of upright posture on a 10 mmol sodium intake). The latter group was further divided into nonmodulators (n= 15) and modulators (n= 16) according to the capability to modulate (1) the plasma aldosterone response to a graded infusion of angiotensin II on a low Na+ intake and (2) the PAH clearance response to a graded infusion of angiotensin II on a high Na+ intake.5 In agreement with several previous reports by Williams and colleagues,57.12.13 in our study too a few patients (n=2) had a mild positivity for the aldosterone criterion while showing a normal PAH clearance response to infused angiotensin II. As a consequence, these patients were classified in the modulator subgroup. In baseline conditions (Table 1) , the three patient subgroups were comparable with respect to age, weight, blood pressure, duration of hypertension, serum creatinine, fasting glucose, HDL and LDL cholesterol, plasma norepinephrine, epinephrine, and dopamine levels. On the contrary, nonmodulating hypertensive patients showed significantly higher fasting plasma insulin (P<.05) than low-renin and modulating hypertensive and normotensive individuals. As already demonstrated,14 red blood The PAH clearance and plasma aldosterone responses to repeated angiotensin II infusions during the low and the high sodium intake are shown in Table 2 and Fig 2 (top) , respectively. As is shown, when patients were on a low sodium intake, PAH clearances were similar in all groups both before and during the angiotensin II infusion. On the contrary, on a high Na+ intake, nonmodulators had a mild decrease of PAH clearance with angiotensin II infusion that resulted in significantly lower clearance than observed in modulating patients.
Also, in the nonmodulating phenotype, the plasma aldosterone increment observed during the angiotensin II infusion performed on a low sodium intake clearly indicated an impaired responsiveness of the zona glomerulosa cells to the infused peptide (Fig 2, top left) . Similarly, the complete pattern of nonmodulation was confirmed by the reduced PRA decrease during the same infusion (Fig 2, middle left) .
With regard to plasma ANP, our results confirmed that the ANP response to angiotensin II is impaired in nonmodulating hypertensive subjects during both a low- (Fig 2, bottom left) and a high-sodium diet (Fig 2,  bottom right) . Low-renin patients showed the highest levels of plasma ANP both at baseline and at the end of the angiotensin II infusion, regardless of sodium intake (Fig 2, bottom) . Moreover, compared with normotensive control subjects, nonmodulating and modulating hypertensive subjects had similar basal plasma ANP levels on both diets (Fig 2, bottom As expected, PRA levels were incompletely suppressed by saline infusion in nonmodulators compared with the other hypertensive (P<.0001 at 120 minutes) and normotensive (P<.02 at 120 minutes) control subjects (Fig 3, second panel) . The plasma aldosterone response also was delayed in nonmodulators compared with normotensive subjects and the other hypertensive subgroups (Fig 3, top) . In regard to renal sodium handling, baseline urinary sodium excretion was similar in all hypertensive subgroups and in normotensive control subjects, ranging from 9.1±2.5 ,uEq/min in lowrenin hypertensive patients to 6.9±3.3 ,Eq/min in normotensive control subjects (Fig 3, bottom) hypertensive patients showed their typical delayed natriuretic response to saline infusion (Fig 3, bottom) . In fact, although the urinary excretion of sodium increased significantly in nonmodulators as well (P<.05 at 60, 120, and 180 minutes), their natriuretic response to saline infusion was significantly lower (P<.0001) than in modulating and low-renin hypertensive patients and in normal control subjects at 60 and 120 minutes (Fig 3,  bottom) .
When the data obtained on a high-Na+ diet were analyzed, no differences in PRA response to sodium load were observed among the different subgroups. In particular, PRA levels were suppressed after the 14-day period on a high-Na+ intake in all patients, and slight further decrements were observed during saline infusion in all groups (Fig 4, second panel) . Plasma aldosterone levels also were suppressed by the high sodium intake in all subjects, and similar decreases were induced by saline infusion in all subgroups (Fig 4,  top) .
It was of particular interest to note that the high Na+ intake increased plasma ANP levels in modulators (from 10 17 .81+4.10 fmol/mL, P<.002). The increase in plasma ANP levels due to dietary sodium supplementation was more pronounced in low-renin patients than in other hypertensive patients. Accordingly, as observed during the low-NaCl diet, plasma peptide levels after dietary NaCl supplementation were still higher (P<.005) in low-renin patients than in the other two hypertensive groups and normotensive subjects (Fig 4, third panel) .
Despite the normality of the plasma ANP response to dietary NaCl load, the cardiac hormone showed a delayed increase during saline infusion in nonmodulators (from 18.84±2.74 to 21.15±3.84 fmol/mL at 120 minutes, P=NS) but not in the other patients. In particular, a significant (P<.05 versus baseline) and rapid increment in plasma ANP was observed during saline infusion in both the remaining hypertensive patients and the control group (Fig 4, third panel) .
As already shown by other reports,7 042 saline infusion induced nonsignificant changes in renal plasma flow or blood pressure in all patients. In contrast, urinary sodium excretion increased significantly with saline infusion in all patient subgroups (Fig 4, bottom) . Also in this case, the natriuretic response to saline load was delayed in nonmodulators, being lower (P<.0001) than in low-renin and modulating hypertensive patients and in normotensive subjects at 60 and 120 minutes (Fig  4, bottom) . During recovery (ie, at 180 minutes), the urinary sodium excretion was slightly but insignificantly reduced in nonmodulating hypertensive patients compared with the other subgroups (Fig 4, bottom) . Salt Sensitivity As far as the blood pressure sensitivity to changes in sodium intake is concerned, our data confirmed the well-known salt sensitivity of low-renin and nonmodulating hypertensive patients. In fact, at the end of the 2 weeks on a high sodium intake, both the systolic and the diastolic blood pressures were significantly higher than at the end of the normal sodium intake in low-renin patients (systolic, from 168.4+4.5 to 175.9+5.4 mm Hg, P<.001; diastolic, from 99.3±2.1 to 108.5±4.3 mm Hg, P<.0001) and in nonmodulators (systolic, from 165.4±4.0 to 169.7±3.2 mm Hg, P<.005; diastolic, from 98.5±2.7 to 105.4±3.2 mm Hg, P<.0001). As expected, no significant salt-related changes were observed in modulators and normotensive control subjects. In a similar way, compared with the normal sodium intake, the low-sodium intake significantly reduced both systolic and diastolic blood pressures in low-renin (systolic, P<.01; diastolic, P<.001) and nonmodulating (systolic, P<.05; diastolic, P<.005) hypertensive patients, while it was ineffective in modulators and control subjects. 
Discussion
We demonstrate for the first time in this study that nonmodulating hypertensive patients showed an impaired plasma ANP response to saline infusion compared with low-renin and modulating hypertensive patients. Chronic dietary NaCl supplementation increased normal plasma ANP levels in all patients. However, when saline infusion was repeated on a high-salt diet, circulating ANP levels failed to increase further in nonmodulators.
As is known, a target-tissue refractoriness to angiotensin II has been suggested as the primary cause of nonmodulating essential hypertension.12 '13 The facts that angiotensin II did not increase ANP levels in nonmodulators,16 whereas it promoted ANP release in unselected subjects16,25,26 and dogs,27 and that angiotensin II itself may raise ANP secretion from isolated rat28 and rabbit heart29 gave rise to our hypothesis'6 that angiotensin II sensitivity could be primarily impaired at the myocyte level in nonmodulators. Nevertheless, circulating ANP levels failed to increase even after saline infusion in these patients. In this context, the role for an impaired angiotensin II sensitivity as well as for a primary abnormality in the cellular mechanisms of stretch-secretion coupling30 is questionable, since oral chronic NaCl supplementation was followed by a normal ANP increase.
As a consequence, it seems possible that the abnormal ANP response to saline infusion is also related to a different fluid compartmentalization into the vascular bed. In accordance with this hypothesis, several studies carried out in hypertensive patients have demonstrated that saline infusion may result in variable natriuretic, hormonal, and hemodynamic responses in hypertensive patients matched for age, race, sex, duration of hypertension, degree of target organ damage, and baseline blood pressure levels.1017"18'31-35 With regard to plasma ANP, an impairment of its release after saline load has already been demonstrated in patients showing several hormonal and renal characteristics of nonmodulators.1718 Moreover, the possibility that differences in intravascular distribution of volume load may influence the response to acute saline load has been suggested by some studies, indicating that borderline hypertensive patients unable to suppress PRA and increase ANP in response to saline infusion (ie, two hormonal characteristics of nonmodulators) had an abnormal venous distensibility during the same infusion. [35] [36] [37] [38] In keeping with this hypothesis, the same patients showed normal ANP and venous distensibility responses to dietary NaCl supplementation.39 Furthermore, the latter revealed in these patients another characteristic feature of nonmodulation, ie, salt sensitivity.39 Therefore, it could be hypothesized that the abnormal ANP response to intravenous saline load observed in nonmodulators may reflect a different intravascular distribution of volume load. However, measurements of body fluid distribution were not performed in this study, and we can only speculate on the matter.
On the other hand, our findings could offer alternative explanations for some of the renal and hormonal abnormalities shown by nonmodulators. First, the blunted ANP response to saline infusion could be a observed in these patients. As in previous reports,17 '18 we did not find any significant correlation between plasma ANP levels and urinary sodium excretion. Nonetheless, it does not seem arbitrary to hypothesize that the reduced response of a natriuretic substance, ie, ANP, might contribute to the delayed sodium excretory response to saline loading. In contrast with this hypothesis, captopril has been reported to normalize sodium excretion738 but not ANP increase38 after saline infusion in nonmodulators7 and in essential hypertensive patients with several characteristics reminiscent of those observed in nonmodulators.38 Therefore, the impaired renal response to saline load should be due to more complicated mechanisms, probably involving the blunted PRA response to sodium load.
In this context, our results confirmed that PRA suppression due to both angiotensin 1113, 16 18 supporting the hypothesis that a reduced ANP release during volume loading could contribute to the abnormalities of PRA behavior and sodium excretory capability in these patients. In agreement with this hypothesis, Singer et al45'46 demonstrated that a sustained suppression of the angiotensin II levels is fundamental in determining the early sodium excretion after a saline load. Therefore, an ANP-related lack of renin suppression could represent a main contributor to the reduced ability to excrete a sodium load shown by nonmodulators.
Alternative explanations for our findings seem to be unlikely. In particular, in agreement with previous reports,712 we found that renal plasma flow and blood pressure response to saline load were not significantly different among patient subgroups. As a consequence, the delay in sodium excretion shown by nonmodulators cannot be related to different blood pressure levels achieved during saline load. In accordance with this interpretation, Rystedt et a17 asserted that the exaggerated natriuresis that follows a saline infusion in lowrenin patients is not due to parallel pressor response. Furthermore, compared with nonmodulators, modulators showed a normal natriuretic response to saline, even though blood pressure levels did not change with acute volume expansion in both groups.7 In this context, a different renal plasma flow response to saline load cannot have determined the impaired sodium excretory response to saline shown by nonmodulators. Indeed, as already demonstrated,7"12"13 the time required for renal blood flow to increase after a sodium load involves many more hours than required for the fall in PRA and the increase in plasma ANP levels and sodium excretion.
In the present study, we confirmed that nonmodulators show a marked salt sensitivity of blood prescontributor to the reduced urinary excretion of sodium sure.5,6,12,13,16 Williams and Hollenberg12,13,47,48 sug-gested that the lack of renal blood flow changes in response to chronic dietary NaCl supplementation could lead to an inappropriate state of sodium retention and, as a consequence, determine the increase in blood pressure.48 This hypothesis could be supported by our data, confirming the presence of an altered renal blood flow response to dietary NaCl supplementation in nonmodulators (Table 2 ). In light of these findings, the normality of the ANP response to chronic sodium loading suggests that the peptide does not play a significant role in determining the abnormal responses of blood pressure and renal blood flow to dietary NaCl supplementation. In agreement with this hypothesis, normal and even exaggerated ANP response to dietary NaCl supplementation have been demonstrated in saltsensitive normotensive49 and hypertensive patients. 50 With regard to family history of hypertension, our data totally agree with previous findings, demonstrating that the nonmodulating phenotype can be observed in the normotensive offspring of essential hypertensive subjects5' and that 84% of nonmodulators have a positive family history of hypertension compared with 25% to 30% in the other hypertensive patients.4"13'52'53 On the other hand, impaired PRA, aldosterone, ANP, and natriuretic responses to saline infusion have been described recently in hypertensive patients having a parental history of cardiovascular events.'7'8 In this report, a positive family history of myocardial infarction seemed more frequent in nonmodulators, but the small number of subjects studied does not allow any speculation on this matter. Indeed, family histories were often positive for both hypertension and cardiovascular events in nonmodulators, suggesting that hypertension is responsible for this finding.
In the present study, we selected only nonobese hypertensive patients with normal carbohydrate and lipid metabolisms. Nevertheless, fasting insulin levels were significantly higher in nonmodulators than in other hypertensive subgroups. The same patients also showed the highest triglyceride and total cholesterol and the lowest HDL cholesterol levels. The reasons leading to these findings are unclear. Fasting hyperinsulinemia is often observed in insulin-resistant conditions.54 Moreover, a reduced insulin sensitivity has been observed recently in salt-sensitive normotensive individuals,55 while mild fasting hyperinsulinemia is more frequent in salt-sensitive than in salt-resistant essential hypertensive patients.'6'56 Taken together, these findings could suggest a possible link among insulin resistance, hyperdyslipidemia, sodium sensitivity, and nonmodulation. In accordance with this hypothesis, we confirmed that erythrocytes from nonmodulating hypertensive patients show increased Na+/Li+ countertransport activity compared with those from low-renin and modulating hypertensive patients'4 ( Table 1) . As is known, erythrocyte Na+/Li+ countertransport activity is accelerated in hypertensive patients with hyperdyslipidemia57'58 and insulin resistance59 and in hypertensive and normotensive subjects with a positive family history of essential hypertension. [60] [61] [62] These data lead to the fascinating theory that an increased Na+/Li+ countertransport activity in vitro may reflect an increased Na+ /H+ antiport activity in vivo. 63 The aforementioned should influence decided to assess the nonmodulating phenotype only in male hypertensive patients.
In conclusion, the present study demonstrates that ANP release during saline infusion is impaired in a patient subset already identified by Williams, Hollenberg, and colleagues as nonmodulating hypertensive patients.5-'5 On the contrary, the ANP response to a 14-day period of high NaCl intake was normal in the same patients. The delayed ANP response to saline infusion could participate in reducing both the renin and sodium excretory responses to saline loading. Conversely, the normality of the ANP response to dietary NaCl load suggests that the peptide has a poor role in determining the marked blood pressure sensitivity to NaCl intake that represents a common feature of the nonmodulating phenotype. In this context, the impairment of ANP regulation as well as the presence of some characteristics reminiscent of those observed in insulinresistant conditions,5265'73 such as elevated Na+ /Li+ countertransport and fasting hyperinsulinemia, further supports the hypothesis that nonmodulation is a multifaceted syndrome, involving both renal and extrarenal abnormalities.
